3D imaging of colorectal cancer organoids identifies responses to Tankyrase inhibitors

Abstract excerpt

Aberrant activation of the Wnt signalling pathway is required for tumour initiation and survival in the majority of colorectal cancers. The development of inhibitors of Wnt signalling has been the focus of multiple drug discovery programs targeting colorectal cancer and other malignancies associated with aberrant pathway activation. However, progression of new clinical entities targeting the Wnt pathway has been...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Cells and Metastasis
• Share to Hippo pathway signaling and YAP/TAZ
• Share to Wnt/β-catenin signaling in development and cancer